This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Compounding Pharmacy Compliance

Our best pricing ends in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
June 9-10, 2026
Hilton Philadelphia at Penn's LandingPhiladelphia, PA

May Alnakkash
Corporate Manager, Document Control at Quva
Speaker

Profile

May Alnakkash brings approximately 10 years of pharmaceutical expertise, with in-depth experience in pharmacy operations and Document Control. With a strong regulatory focus and a commitment to product quality and patient safety, she serves as Corporate Document Control at QuVa Pharma, where her goal is to maintain and enhance the Document Control Program in alignment with industry standards.

As an active member of the PDA Texas Chapter, May stays current with evolving industry guidelines and emerging advancements in pharmaceutical document control. Her expertise extends beyond her role as a pharmacist and encompasses a broad range of functions throughout the years, including Operations (Post-Compounding and Formulation), Quality (Investigations, Good Documentation Practices, and Corporate Quality Systems), and Pharmacy Services (development of batch records [BR], bills of materials [BOM], and electronic batch records [eBR]). Through her leadership, May supports multiple facets of the organization and contributes to QuVa Pharma’s continued growth.

Agenda Sessions

  • Standardizing Quality Systems Across States: From CAPAs to Continuous Improvement

    2:30pm
  • 503B Regulatory Update and Evolving FDA Focus: Strengthening Oversight and Operational Readiness

    9:00am